These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12231413)
1. Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats. Mo A; Yao W; Li C; Tian X; Su M; Ling Y; Zhang Q; Setterberg RB; Jee WS Bone; 2002 Sep; 31(3):402-6. PubMed ID: 12231413 [TBL] [Abstract][Full Text] [Related]
2. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat. Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795 [TBL] [Abstract][Full Text] [Related]
3. Bipedal stance exercise enhances antiresorption effects of estrogen and counteracts its inhibitory effect on bone formation in sham and ovariectomized rats. Chen JL; Yao W; Frost HM; Li CY; Setterberg RB; Jee WS Bone; 2001 Aug; 29(2):126-33. PubMed ID: 11502473 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy. Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919 [TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats. Ke HZ; Li M; Jee WS Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347 [TBL] [Abstract][Full Text] [Related]
7. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats. Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783 [TBL] [Abstract][Full Text] [Related]
8. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962 [TBL] [Abstract][Full Text] [Related]
9. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377 [TBL] [Abstract][Full Text] [Related]
10. Making rats rise to erect bipedal stance for feeding partially prevented orchidectomy-induced bone loss and added bone to intact rats. Yao W; Jee WS; Chen J; Liu H; Tam CS; Cui L; Zhou H; Setterberg RB; Frost HM J Bone Miner Res; 2000 Jun; 15(6):1158-68. PubMed ID: 10841185 [TBL] [Abstract][Full Text] [Related]
11. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465 [TBL] [Abstract][Full Text] [Related]
12. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH. Iwaniec UT; SamnegÄrd E; Cullen DM; Kimmel DB Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618 [TBL] [Abstract][Full Text] [Related]
13. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat. Ito H; Ke HZ; Jee WS; Sakou T Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632 [TBL] [Abstract][Full Text] [Related]
15. Erect bipedal stance exercise partially prevents orchidectomy-induced bone loss in the lumbar vertebrae of rats. Yao W; Jee WS; Chen J; Tam CS; Setterberg RB; Frost HM Bone; 2000 Nov; 27(5):667-75. PubMed ID: 11062354 [TBL] [Abstract][Full Text] [Related]
16. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats. Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081 [TBL] [Abstract][Full Text] [Related]
17. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats. Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930 [TBL] [Abstract][Full Text] [Related]
18. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats. Erben RG; Bromm S; Stangassinger M Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. Jee WS; Mori S; Li XJ; Chan S Bone; 1990; 11(4):253-66. PubMed ID: 2242291 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study. Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]